|
Title
|
Opportunity Number
|
Funding Agency
|
Deadline
|
|
Exploratory/Developmental Bioengineering Research Grants
Data Science, Public Health, and Biotechnology
|
Opportunity Number
PAR-25-346
|
Funding Agency
NIH (NCI, NIDCR)
|
Deadline
Feb 16 2026
|
|
2026 NIAID DMID Omnibus Broad Agency Announcement
Infectious Diseases, Vaccine, Therapeutics, and Public Health
|
Opportunity Number
HHS-NIH-NIAID-BAA2025-1
|
Funding Agency
NIH (NIAID)
|
Deadline
Feb 21 2026
|
|
Basic Research in Cancer Health Disparities
Cancer, Health Disparities, and Epidemiology
|
Opportunity Number
PAR-25-244
|
Funding Agency
NIH (NCI)
|
Deadline
Feb 16 2026
|
|
NIDCR Small Grant Program for New Investigators
Operational Medicine, Dental and Oral Health, and Education and Training
|
Opportunity Number
PAR-25-105
|
Funding Agency
NIH (NIDCR)
|
Deadline
Feb 16 2026
|
|
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia
Psych Health, Brain Health, Therapeutics, and Education and Training
|
Opportunity Number
PAR-25-065
|
Funding Agency
NIH (NIMH, NIA)
|
Deadline
Feb 5 2026
|
|
Modular R01s in Cancer Control and Population Sciences
Cancer, Date Science, and Epidemiology
|
Opportunity Number
PA-25-172
|
Funding Agency
NIH (NCI)
|
Deadline
Feb 5 2026
|
|
Large Research Projects for Combating Antibiotic-Resistant Bacteria (CARB) (R01)
Infectious Diseases
|
Opportunity Number
PA-22-047
|
Funding Agency
NIH
|
Deadline
Feb 5 2026
|
|
Large Research Projects for Prevention of Healthcare-Associated Infections (R01)
|
Opportunity Number
PA-21-265
|
Funding Agency
NIH
|
Deadline
Oct 31 2026
|
|
Assay Validation of High Quality Markers for Clinical Studies in Cancer
Cancer, Biomarkers
|
Opportunity Number
PAR-25-074
|
Funding Agency
NCI
|
Deadline
Feb 13 2026
|
|
Morris K. Udall Discovery Centers without Walls (DCWoW) for Parkinson's Disease Research
Psychological Health, Neurology
|
Opportunity Number
NOT-NS-24-061
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
BAA for Extramural Biomedical and Human Performance Research
Operational Medicine, Combat Casualty Care, CBRNE, Human Performance, Canine
|
Opportunity Number
HT9425-23-S-SOC1
|
Funding Agency
USSOCOM
|
Deadline
Jul 31 2028
|
|
CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin
CBRNE, Wound
|
Opportunity Number
PA-25-093
|
Funding Agency
NIH
|
Deadline
Feb 16 2026
|
|
Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders
Psychological Health, Neurology, Brain Health
|
Opportunity Number
PAR-25-050
|
Funding Agency
NIH
|
Deadline
Feb 20 2026
|
|
Viral Infections in the Young Lung
Infectious Diseases, Pulmonary
|
Opportunity Number
NOT-HL-24-027
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
Army Applications Lab Broad Agency Announcement For Disruptive Applications
Operational Medicine, Human Performance, Artificial Intelligence (AI)
|
Opportunity Number
W911NF-24-S-0008
|
Funding Agency
Army Applications Lab
|
Deadline
Apr 4 2029
|
|
Biological Threat Reduction with Global Partners Broad Agency Announcement (BAA)
CBRNE, Biosecurity, Infectious Diseases
|
Opportunity Number
HDTRA1-24-S-0002
|
Funding Agency
DTRA
|
Deadline
Apr 28 2029
|
|
Broad Agency Announcement Research and Development In Support of The Joint Program Executive Office For Chemical, Biological, Radiological And Nuclear Defense (JPEO-CBRND), JPM MEDICAL AND JPL EB
CBRNE, Biosecurity, Vaccine, Biotechnology
|
Opportunity Number
W911SR-22-R-CBRN
|
Funding Agency
DOD
|
Deadline
Jun 26 2027
|
|
Biomarkers or Biomarker Signatures for Neurological and Neuromuscular Disorders
Neurology, Diagnostics, Brain Health
|
Opportunity Number
PAR-25-024
|
Funding Agency
NIH (NINDS)
|
Deadline
Feb 20 2026
|
|
BARDA Broad Agency Announcement (BAA)
CBRNE, Biotechnology, Biosecurity, Public Health
|
Opportunity Number
BAA-23-100-SOL-00004
|
Funding Agency
BARDA
|
Deadline
Sep 25 2028
|
|
BARDA DRIVe EZ-BAA
CBRNE, Biotechnology, Biosecurity, Public Health
|
Opportunity Number
EZBAA - 22-100-SOL-00003
|
Funding Agency
BARDA
|
Deadline
Oct 18 2027
|
|
Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research (R03 Clinical Trial Optional)
Psych Health, Aging, Epidemiology
|
Opportunity Number
PA-25-246
|
Funding Agency
NIH (NIA)
|
Deadline
Feb 16 2026
|
|
DEVCOM Army Research Laboratory BAA for Foundational Research
Data Science, Biosensing, Artificial Intelligence, Biotechnology
|
Opportunity Number
W911NF-23-S-0001
|
Funding Agency
DoD
|
Deadline
Nov 20 2027
|
|
Molecular and Cellular Computational Tools Supporting Fundamental Neuroscience Research
Psych Health, Neurology, Model Development
|
Opportunity Number
NOT-MH-25-045
|
Funding Agency
NIH (NIMH)
|
Deadline
May 10 2028
|
|
Military and Civilian Partnership for Trauma Readiness Grant Program/Mission Zero
Combat Casualty Care, Trauma, Wound
|
Opportunity Number
EP-HIT-25-02
|
Funding Agency
ASPR
|
Deadline
Forecasted
|
|
CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System
CBRNE
|
Opportunity Number
PAR-25-077
|
Funding Agency
NIH
|
Deadline
Oct 16 2026
|
|
Interventions to Reduce Sleep Health Disparities
Operational Medicine, Sleep
|
Opportunity Number
PAR-24-330
|
Funding Agency
NIH
|
Deadline
Feb 5 2026
|
|
Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders
Psych Health, Biotechnology, Model Development
|
Opportunity Number
PAR-25-290
|
Funding Agency
NIH
|
Deadline
Feb 5 2026
|
|
Navigator Emergency Department Diversion Models for Non-urgent mental health concerns
Operational Medicine, Triage Support, Mental and Behavioral Health
|
Opportunity Number
PAR-25-288
|
Funding Agency
NIH
|
Deadline
Feb 16 2026
|
|
Research Project Grant (Parent R01 Clinical Trial Not Allowed)
Varies
|
Opportunity Number
PA-25-301
|
Funding Agency
NIH
|
Deadline
Feb 5 2026
|
|
Broad Agency Announcement for Basic and Applied Research at the US Army Combat Capabilities Development Command - Soldier Center
Human Performance, CBRNE, AI, Biotechnology
|
Opportunity Number
W911QY25R0023
|
Funding Agency
DoD
|
Deadline
Mar 14 2030
|
|
ARPA-H Office Wide Innovative Solutions Opening for Health Science Futures (HSF)
|
Opportunity Number
ARPA-H-SOL-24-104
|
Funding Agency
ARPA-H
|
Deadline
Mar 3 2029
|
|
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
Operational Medicine
|
Opportunity Number
PAR-24-280
|
Funding Agency
NIH
|
Deadline
Mar 4 2026
|
|
Fundamental Research to Counter Weapons of Mass Destruction (FRCWMD)
CBNRE, Detection, Countermeasures, Diagnostics
|
Opportunity Number
HDTRA1-25-S-0001
|
Funding Agency
DTRA
|
Deadline
Sep 30 2034
|
|
NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed)
Dental and Oral Health, Epidemiology, Biomarkers, Data Science
|
Opportunity Number
PAR-25-239
|
Funding Agency
NIH
|
Deadline
Feb 5 2026
|
|
Disability and Rehabilitation Engineering (DARE)
Rehabilitation, Robotics, Brain Health
|
Opportunity Number
PD 23-5342
|
Funding Agency
NSF
|
Deadline
Dec 31 2025
|
|
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
Musculoskeletal, Physical Therapy, Biomarkers
|
Opportunity Number
PAR-24-279
|
Funding Agency
NIH
|
Deadline
Mar 4 2026
|
|
NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed)
Sensory Systems, Data Science, Epidemiology
|
Opportunity Number
PAR-25-357
|
Funding Agency
NIH
|
Deadline
Feb 16 2026
|
|
Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)
|
Opportunity Number
PAR-25-230
|
Funding Agency
NIH
|
Deadline
Dec 5 2025
|
|
Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)
|
Opportunity Number
PA-25-169
|
Funding Agency
NIH
|
Deadline
Feb 16 2026
|
|
Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed)
|
Opportunity Number
PAR-24-289
|
Funding Agency
NIH
|
Deadline
Dec 5 2025
|
|
NIH Research Project Grant (Parent R01 Clinical Trial Required)
|
Opportunity Number
PA-25-305
|
Funding Agency
NIH
|
Deadline
Feb 5 2026
|
|
NIDCR Research Grants for Analyses of Existing Genomics Data (R01) (Clinical Trial Not Allowed)
Dental and Oral Health
|
Opportunity Number
PAR-25-164
|
Funding Agency
NIH
|
Deadline
Feb 5 2026
|
|
Focused Technology Research and Development (R01 Clinical Trial Not Allowed)
|
Opportunity Number
PAR-25-203
|
Funding Agency
NIH
|
Deadline
Feb 5 2026
|
|
AHRQ Health Services Research Projects (R01)
|
Opportunity Number
PA-24-154
|
Funding Agency
NIH/AHRQ
|
Deadline
Feb 5 2026
|
|
NHLBI Program Project Applications (P01 Clinical Trials Optional)
|
Opportunity Number
|
Funding Agency
NIH
|
Deadline
Jan 25 2026
|
|
Broad Agency Announcement for Fundamental AI Research
Data Analytics
|
Opportunity Number
W519TC-25-S-0001
|
Funding Agency
DoD
|
Deadline
Forecasted
|
|
NEI Collaborative Clinical Vision Research Project: Resource Center Grant (UG1 Clinical Trial Required)
|
Opportunity Number
PAR-23-201
|
Funding Agency
NIH
|
Deadline
Jan 25 2026
|
|
NEI Clinical Research Study Planning Grant Program (R34 Clinical Trial Not Allowed)
|
Opportunity Number
PAR-25-358
|
Funding Agency
NIH
|
Deadline
Feb 16 2026
|
|
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
|
Opportunity Number
PAR-25-026
|
Funding Agency
NIH
|
Deadline
Feb 3 2026
|
|
NSF Faculty Early Career Development Program (CAREER)
|
Opportunity Number
NSF 22-586
|
Funding Agency
NSF
|
Deadline
Jul 22 2026
|
|
Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
|
Opportunity Number
PAR-24-325
|
Funding Agency
NIH
|
Deadline
Jan 27 2026
|
|
USAMRDC FY23-FY27 BAA for Extramural Medical Research
|
Opportunity Number
|
Funding Agency
DoD
|
Deadline
Sep 30 2027
|
|
Research Interests of the Air Force Office of Scientific Research (FY25-FY28)
|
Opportunity Number
FA955025S0001
|
Funding Agency
DAF
|
Deadline
May 18 2028
|
|
HEAL: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional)
|
Opportunity Number
FOR-DA-26-001
|
Funding Agency
DHHS
|
Deadline
Forecasted
|
|
Resource-based Centers for Bone, Muscle and Orthopaedic Research
|
Opportunity Number
FOR-AR-26-004
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
Mind and Body Interventions to Restore Whole Person Health via Emotional Well-Being Mechanisms
|
Opportunity Number
NOT-AT-25-006
|
Funding Agency
NIH
|
Deadline
Jun 7 2028
|
|
HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional
|
Opportunity Number
FOR-NS-25-002
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
Advancing Nutrition-related Research Across the Lifespan
|
Opportunity Number
FOR-NR-25-001
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
Joint NINDS/NIMH Exploratory Neuroscience Research Grant (R21 Clinical Trial Not Allowed)
|
Opportunity Number
PA-25-150
|
Funding Agency
NIH
|
Deadline
Feb 16 2026
|
|
Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care (R21/R33 - Clinical Trial Optional)
|
Opportunity Number
PA-24-266
|
Funding Agency
AHRQ
|
Deadline
Feb 16 2026
|
|
BAA for Navy and Marine Corps Science and Technology
|
Opportunity Number
N0001425SB001
|
Funding Agency
ONR
|
Deadline
Sep 30 2026
|
|
BAA Naval Air Warfare Center Aircraft Division Office-Wide
|
Opportunity Number
N00421-25-S-0001
|
Funding Agency
DoD-ONR-AIR
|
Deadline
Jun 22 2026
|
|
HEAL Initiative: Integrative Management of Chronic Pain and Opioid Use Disorder (OUD) for Whole Recovery: Health Systems
Pain Management, Drug Addiction
|
Opportunity Number
FOR-DA-27-001
|
Funding Agency
NIH/DHHS
|
Deadline
Forecasted
|
|
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
|
Opportunity Number
FOR-CA-25-075
|
Funding Agency
NIH/DHHS
|
Deadline
Forecasted
|
|
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
|
Opportunity Number
FOR-CA-25-074
|
Funding Agency
NIH/DHHS
|
Deadline
Forecasted
|
|
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
|
Opportunity Number
FOR-CA-25-073
|
Funding Agency
NIH/DHHS
|
Deadline
Forecasted
|
|
NIAID Clinical Trial Implementation Cooperative Agreement
|
Opportunity Number
FOR-AI-27-007
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
NIH and CDC Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Required)
|
Opportunity Number
FOR-OD-26-002
|
Funding Agency
NIH/CDC
|
Deadline
Forecasted
|
|
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
|
Opportunity Number
FOR-OD-26-001
|
Funding Agency
NIH/CDC/FDA
|
Deadline
Forecasted
|
|
Medics Autonomously Stopping Hemorrhage (MASH)
|
Opportunity Number
|
Funding Agency
DARPA
|
Deadline
Nov 25 2025
|
|
Eliminating Parasitic and Neglected Tropical Disease Threats to the United States - Program Support and Research to Reduce Threats to Americans at Home and Abroad
Infectious Disease
|
Opportunity Number
RFA-CK-26-104
|
Funding Agency
HHS-CDC
|
Deadline
Forecasted
|
|
Continuing Human Enabling, Enhancing, Restoring, and Sustaining (CHEERS) Multiple Authority Announcement (MAA) Open Period 1
|
Opportunity Number
FA238424S2334
|
Funding Agency
DoD Air Force Research Lab
|
Deadline
Forecasted
|
|
Continuing Human Enabling, Enhancing, Restoring, and Sustaining (CHEERS) Multiple Authority Announcement (MAA) Open Period 2
|
Opportunity Number
FA238424S2335
|
Funding Agency
DoD Air Force Research Lab
|
Deadline
Sep 30 2027
|
|
Research Grants for Preventing Violence and Violence Related Injury (R01)
|
Opportunity Number
RFA-CE-26-020
|
Funding Agency
NIH/DHHS
|
Deadline
Forecasted
|
|
Maximizing Investigators Research Award (MIRA) for Early Stage Investigators (ESI) (R35 - Clinical Trial Optional)
|
Opportunity Number
PAR-23-145
|
Funding Agency
NIH
|
Deadline
Feb 3 2026
|
|
USAMRDC BAA Addendum - Military Family Health Research
|
Opportunity Number
|
Funding Agency
USAMRDC
|
Deadline
Sep 30 2027
|
|
Selective Precision Targeting (SPoT)
|
Opportunity Number
FOR-TR-27-003
|
Funding Agency
NIH/NCATS
|
Deadline
Forecasted
|
|
Impact of Environmental Exposures on Gut-Brain Signaling in Neurological Conditions (R01)
|
Opportunity Number
|
Funding Agency
NIH (NIEHS)
|
Deadline
Forecasted
|
|
Extracellular Vesicle Therapeutics for Regenerative Medicine (ExTReMe)
|
Opportunity Number
FOR-TR-27-002
|
Funding Agency
NIH/NCATS
|
Deadline
Forecasted
|
|
AFIRM Advancing Therapeutic Reprogramming for Military Regenerative Medicine
|
Opportunity Number
AFIRM 002
|
Funding Agency
DHA/AFIRM
|
Deadline
Deadline Extended
|
|
Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)
|
Opportunity Number
FOR-LM-25-001
|
Funding Agency
DHHS
|
Deadline
Forecasted
|
|
Transformative Non-Invasive/Minimally Invasive Technologies for Imaging the Olfactory System Across Scales (R01 Clinical Trial Optional)
|
Opportunity Number
NOT-DC-25-035
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Human Required)
|
Opportunity Number
PAR-25-323
|
Funding Agency
NIH
|
Deadline
Jan 27 2026
|
|
Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)
|
Opportunity Number
PAR-25-322
|
Funding Agency
NIH
|
Deadline
Jan 27 2026
|
|
Partnerships for Development of Vaccines to Prevent MycobacteriumTuberculosis Infection and/or Disease (R01 Clinical Trial Not Allowed)
|
Opportunity Number
RFA-AI-25-022
|
Funding Agency
NIH
|
Deadline
Nov 25 2025
|
|
Research Grants in Clinical Informatics (R01 Clinical Trial Optional)
|
Opportunity Number
FOR-LM-25-002
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Required)
|
Opportunity Number
FOR-OD-26-007
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
New Generation of Glucose Control Technologies Incorporating AI/ML Tools/Strategies
|
Opportunity Number
NOT-DK-26-307
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)
|
Opportunity Number
RFA-TS-26-165
|
Funding Agency
CDC
|
Deadline
Forecasted
|
|
Influenza Modeling and Forecasting
|
Opportunity Number
CDC-RFA-IP-26-0102
|
Funding Agency
CDC
|
Deadline
Forecasted
|
|
Novel approaches to support therapeutic development in ultra-rare cancers
|
Opportunity Number
FOR-FD-26-004
|
Funding Agency
FDA
|
Deadline
Forecasted
|
|
FY26 Mini Evidence-Based Practice Project Funding
|
Opportunity Number
|
Funding Agency
TSNRP
|
Deadline
Aug 31 2026
|
|
TriService Nursing Research Program (TSNRP) High Priority Awards
|
Opportunity Number
|
Funding Agency
TSNRP
|
Deadline
Rolling Basis
|
|
FY25 RAPID High Priority Awards
|
Opportunity Number
|
Funding Agency
TSNRP
|
Deadline
Rolling Basis
|
|
HeartShare 2.0: Refining Heart Failure Subtypes and Treatment Targets for Personalized Clinical Trials - Clinical Trial Center and Clinical Centers (U01 Clinical Trial Optional)
|
Opportunity Number
RFA-HL-26-026
|
Funding Agency
NIH
|
Deadline
Dec 15 2025
|
|
Emerging Infections Network - Research for Preventing, Detecting, and Managing Travel-associated Infectious Diseases
|
Opportunity Number
RFA-CK-26-035
|
Funding Agency
CDC
|
Deadline
Forecasted
|
|
Preparedness for and Prevention of Severe Disease and Sequelae of Respiratory Viruses and Other Respiratory Pathogens
|
Opportunity Number
RFA-IP-26-100
|
Funding Agency
CDC
|
Deadline
Forecasted
|
|
Continuing to Enhance Global Health Security: Sustain Efforts and Strategies to Protect and Improve Public Health Globally
|
Opportunity Number
CDC-RFA-JG-26-0056
|
Funding Agency
CDC
|
Deadline
Forecasted
|
|
Causal Hypotheses on the Oral-Systemic Health Impacts of Human Behaviors among People with Chronic Conditions
|
Opportunity Number
FOR-DE-26-004
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
Grants for Adaptive Sports Programs for Disabled Veterans and Disabled Members of the Armed Forces
|
Opportunity Number
VA-SPORTS-26
|
Funding Agency
VA
|
Deadline
Forecasted
|
|
Interdisciplinary Research to Understand the Complex Biology of Resilience to Alzheimer’s and Related Dementias Disease Risk
|
Opportunity Number
PAR-26-067
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
Translational Center for Accelerating the Use of Digital Health Technologies Data in AD/ADRD Research
|
Opportunity Number
RFA-AG-27-002
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
Eliminating Parasitic and Neglected Tropical Disease Threats to the United States - Program Support and Research to Reduce Threats to Americans at Home and Abroad
|
Opportunity Number
RFA-CK-26-104
|
Funding Agency
CDC
|
Deadline
Forecasted
|
|
Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
|
Opportunity Number
PAR-25-446
|
Funding Agency
NIH
|
Deadline
Aug 21 2028
|
|
BARDA I CREATE Ready Detect: Next-Generation Diagnostics Competition
|
Opportunity Number
|
Funding Agency
BARDA
|
Deadline
Jan 15 2026
|
|
NIDCD Clinical Research Center Grant (P50 Clinical Trial Optional)
|
Opportunity Number
PAR-25-445
|
Funding Agency
NIH
|
Deadline
Jun 2 2028
|
|
BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)
|
Opportunity Number
RFA-DA-27-004
|
Funding Agency
NIH
|
Deadline
Nov 8 2027
|
|
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
|
Opportunity Number
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
|
Opportunity Number
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
Nutrition Obesity Research Centers (NORCs)
|
Opportunity Number
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
Limited Competition: Post-Stroke Vascular Contributions to Cognitive Impairment and Dementia (VCID) in the United States (U19 - Clinical Trial not Allowed)
|
Opportunity Number
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)
|
Opportunity Number
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)
|
Opportunity Number
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required)
|
Opportunity Number
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
George M. O’Brien Urology Cooperative Research Centers Program (U54 Clinical Trial Optional)
|
Opportunity Number
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
Extension of the World Trade Center Health Registry (U50)
|
Opportunity Number
|
Funding Agency
CDC
|
Deadline
Forecasted
|
|
NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access
|
Opportunity Number
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
Kidney Precision Medicine Project Central Hub (U24 Clinical Trial Not Allowed)
|
Opportunity Number
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
Science Track Award for Research Transition (START) Program
|
Opportunity Number
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
Kidney Precision Medicine Project Tissue Interrogation Sites (U01 Clinical Trial Not Allowed)
|
Opportunity Number
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
Kidney Precision Medicine Project Recruitment Sites (U01 Clinical Trial Not Allowed)
|
Opportunity Number
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
Neural Ensembles & Used Substances (NExUS) Collaboratory : Building a Multimodal Inventory of Cell Ensembles Encoding the Effects of Addictive Substances
|
Opportunity Number
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
RRPV (Rapid Response Partnership Vehicle) ASSURE
|
Opportunity Number
|
Funding Agency
RPPV
|
Deadline
Forecasted
|
|
RRPV (Rapid Response Partnership Vehicle) Agnostic Diagnostics
|
Opportunity Number
|
Funding Agency
RPPV
|
Deadline
Nov 20 2025
|
|
RRPV (Rapid Response Partnership Vehicle) Rapid Antibody Production
|
Opportunity Number
|
Funding Agency
RPPV
|
Deadline
Dec 4 2025
|
|
Growing Great Ideas: Research Education Course in Product Development and Entrepreneurship for Life Science Researchers
|
Opportunity Number
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
NIMH Research Education Programs for Psychiatry Residents
|
Opportunity Number
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
NIMH Short Courses for Mental Health Related Research
|
Opportunity Number
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research
|
Opportunity Number
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
Maximizing Investigators’ Research Award (MIRA) for Early Stage Investigators (ESI)
|
Opportunity Number
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities
|
Opportunity Number
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
Biological Testing Facility for Contraception & Reproductive Health
|
Opportunity Number
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
Glioblastoma Therapeutics Network (GTN; U19 Clinical Trial Required)
|
Opportunity Number
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
Smart-Red Blood Cells (Smart-RBC)
|
Opportunity Number
DARPA-PA-26-02
|
Funding Agency
DARPA
|
Deadline
Jan 15 2026
|
|
Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
|
Opportunity Number
PAR-25-450
|
Funding Agency
NIH
|
Deadline
Jul 20 2028
|
|
NSF/CASIS Transport Phenomena Research at the International Space Station to Benefit Life on Earth
|
Opportunity Number
25-529
|
Funding Agency
NSF
|
Deadline
Mar 4 2026
|
|
Pilot Projects to Enhance the Human Virome Program (R03, Clinical Trials Not Allowed)
|
Opportunity Number
RFA-RM-25-006
|
Funding Agency
NIH
|
Deadline
Nov 24 2025
|
|
Advancing Research on the Application of Digital Health Technology to the Management of Type 2 Diabetes (R01- Clinical Trail Required)
|
Opportunity Number
RFA-DK-26-315
|
Funding Agency
NIH
|
Deadline
Oct 6 2026
|
|
Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research
|
Opportunity Number
RFA-DK-27-108
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
The NIDDK Disorders of Gastrointestinal Interoception Consortium Clinical Centers (DGIC)
|
Opportunity Number
RFA-DK-27-117
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
NIBIB Technology Development Networks
|
Opportunity Number
RFA-EB-26-001
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
The NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Genomic Research Centers
|
Opportunity Number
RFA-DK-27-116
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
The NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Data Coordinating Center
|
Opportunity Number
RFA-DK-27-124
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
The NIDDK Disorders of Gastrointestinal Interoception Consortium Clinical Centers (DGIC)
|
Opportunity Number
RFA-DK-27-118
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
Enhancing Global Health Security: Strengthening Public Health Surveillance Systems for Disease Detection and Preparedness Globally
|
Opportunity Number
CDC-RFA-JG-26-0113
|
Funding Agency
CDC
|
Deadline
Forecasted
|
|
NEI New Innovator Award (DP2 Clinical Trial Not Allowed)
|
Opportunity Number
PAR-26-087
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
Interdisciplinary Research Networks to Advance Biomedical Research on Resilience and Health Optimization
|
Opportunity Number
RFA-AT-26-001
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
Centers of Excellence in Genomic Science (CEGS)
|
Opportunity Number
PAR-26-036
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
Toolkits for Dissemination of Genomic Technologies
|
Opportunity Number
PAR-26-037
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
Genetic Medicines and Individualized Manufacturing for Everyone (GIVE)
|
Opportunity Number
|
Funding Agency
ARPA-H
|
Deadline
Dec 19 2025
|
|
Dynamic and Adaptable Infrastructure for Drug Development and Outreach to Aid the Research Community in Advancing Medication Repurposing and Repositioning Efforts for Substance Use Disorders (SUDs) (U54 - Clinical Trials Not Allowed)
|
Opportunity Number
RFA-DA-26-020
|
Funding Agency
NIH
|
Deadline
Jan 28 2026
|
|
Accelerating Research Translation
|
Opportunity Number
25-548
|
Funding Agency
NSF
|
Deadline
Jan 15 2026
|
|
NSF National Innovation Corps Teams (NSF National I-Corps (TM) Teams) program
|
Opportunity Number
25-549
|
Funding Agency
NSF
|
Deadline
Dec 31 2026
|
|
DARPA Biological Technologies BAA FY26
|
Opportunity Number
HR001126S0003
|
Funding Agency
DARPA
|
Deadline
Sep 30 2026
|
|
Single Source for Establishing Pilot/Opportunity program for AI Models to Accelerate Diabetes Research (U24- Clinical Trials not allowed)
|
Opportunity Number
RFA-DK-26-314
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
Collaborative Awards to Support Microphysiological System Pilot Studies in Type 2 Diabetes Research
|
Opportunity Number
PAR-25-456
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
Cooperative Centers of Excellence in Hematology (CCEHs)
|
Opportunity Number
RFA-DK-27-127
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
Discovery of in vivo Chemical Probes for the Nervous System
|
Opportunity Number
PAR-26-095
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
Screening for Conditions by Electronic Nose Technology (SCENT III) (Clinical Trial Not Allowed)
|
Opportunity Number
RFA-TR-26-001
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
ntramural - Extramural Collaboration for Advanced 3-D Tissue Models for Drug Screening (Clinical Trial Not Allowed)
|
Opportunity Number
RFA-TR-25-016
|
Funding Agency
NIH
|
Deadline
Forecasted
|
|
Large Health Services Research Demonstration and Dissemination Projects for Prevention of Healthcare-Associated Infections (R18)
|
Opportunity Number
PA-21-264
|
Funding Agency
AHRQ
|
Deadline
Oct 31 2026
|
|
Large Health Services Research Demonstration and Dissemination Projects for Combating Antibiotic-Resistant Bacteria (CARB)(R18)
|
Opportunity Number
PA-22-048
|
Funding Agency
AHRQ
|
Deadline
Oct 31 2026
|
|
AHRQ Patient-Centered Outcomes Research (PCOR) Mentored Research Scientist Career Development Award (K01)
|
Opportunity Number
PA-22-049
|
Funding Agency
AHRQ
|
Deadline
Mar 13 2026
|
|
AHRQ Patient-Centered Outcomes Research (PCOR) Mentored Clinical Scientist Career Development Award (K08)
|
Opportunity Number
PA-22-050
|
Funding Agency
AHRQ
|
Deadline
Mar 13 2026
|
|
AHRQ Mentored Career Enhancement Awards for Established Investigators in Patient-Centered Outcome Research (K18)
|
Opportunity Number
PA-22-051
|
Funding Agency
AHRQ
|
Deadline
Jul 13 2026
|
|
AHRQ Mentored Clinical Scientist Research Career Development Award (K08)
|
Opportunity Number
PA-22-232
|
Funding Agency
AHRQ
|
Deadline
Feb 14 2027
|
|
AHRQ Small Research Projects to Advance the Science of Primary Care (R03)
|
Opportunity Number
PA-23-115
|
Funding Agency
AHRQ
|
Deadline
Mar 19 2027
|
|
Examining the Impact of Artificial Intelligence (AI) on Healthcare Safety (R18)
|
Opportunity Number
PA-24-261
|
Funding Agency
AHRQ
|
Deadline
May 25 2027
|
|
AHRQ Health Services Research Dissertation Program (R36)
|
Opportunity Number
PA-23-196
|
Funding Agency
AHRQ
|
Deadline
May 26 2028
|
|
AHRQ Improving Diagnostic Safety in Ambulatory Care: Strategies and Interventions (R18)
|
Opportunity Number
PA-23-290
|
Funding Agency
AHRQ
|
Deadline
May 26 2028
|
|
Building National Partnerships for the Prevention of Emerging and Reemerging Infectious Diseases
|
Opportunity Number
CDC-RFA-CK-26-0107
|
Funding Agency
HHS/CDC
|
Deadline
Apr 18 2026
|
|
Mapping Machine Learning to Physics
|
Opportunity Number
DARPA-PS-25-32
|
Funding Agency
DARPA
|
Deadline
Dec 17 2025
|
|
Understanding and Improving Diagnostic Safety in Ambulatory Care: Incidence and Contributing Factors (R01)
|
Opportunity Number
PA-23-291
|
Funding Agency
AHRQ
|
Deadline
Jul 6 2028
|
|
Systems-Based Approaches to Improve Patient Safety by Improving Healthcare Worker Safety and Well-Being (R01 Clinical Trial Optional)
|
Opportunity Number
PA-24-093
|
Funding Agency
AHRQ
|
Deadline
Jan 19 2029
|
|
Small Health Services Research Grant Program (R03)
|
Opportunity Number
PA-24-155
|
Funding Agency
AHRQ
|
Deadline
Jul 17 2029
|
|
Health Services Research Demonstration and Dissemination Grants (R18)
|
Opportunity Number
PA-24-156
|
Funding Agency
AHRQ
|
Deadline
May 26 2029
|
|
Research to Advance the Science of Primary Care (R01)
|
Opportunity Number
PA-24-205
|
Funding Agency
AHRQ
|
Deadline
Nov 5 2029
|
|
Arctic Research Opportunities
|
Opportunity Number
NSF 23-572
|
Funding Agency
NSF
|
Deadline
Jan 15 2026
|
|
RFI: Advanced Technologies for Combat Casualty Care
|
Opportunity Number
DARPA-SN-26-06
|
Funding Agency
DARPA
|
Deadline
Dec 3 2025
|
|
Standardizing Data and Metadata from Wearable Devices (R01 Clinical Trial Not Allowed)
|
Opportunity Number
PAR-24-250
|
Funding Agency
NIH
|
Deadline
Jan 10 2026
|
|
Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)
|
Opportunity Number
PAR-25-243
|
Funding Agency
NIH
|
Deadline
Feb 5 2026
|
|
NSF/CASIS Transport Phenomena Research at the International Space Station to Benefit Life on Earth
|
Opportunity Number
NSF-25-529
|
Funding Agency
NSF
|
Deadline
Jan 12 2026
|
|
RFI: Genomic Sequencing Workflows
|
Opportunity Number
|
Funding Agency
MCDC
|
Deadline
Dec 19 2025
|
|
FORM: Foundations of a Resilient Microbiome
|
Opportunity Number
|
Funding Agency
Wellcome Leap
|
Deadline
Nov 14 2025
|
|
Cardiac Arrest Research Team (CART) Network
|
Opportunity Number
|
Funding Agency
AHA
|
Deadline
Dec 16 2025
|
|
Rapid Impact Research Award
|
Opportunity Number
|
Funding Agency
AHA
|
Deadline
Jan 22 2026
|
|
RFI: Wearable CBRN Threat Monitoring Sensors
|
Opportunity Number
|
Funding Agency
JPEO-CBRND
|
Deadline
Dec 19 2025
|
|
Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)
|
Opportunity Number
PAR-25-325
|
Funding Agency
NIH
|
Deadline
Feb 4 2026
|
|
Using Real-World Data to Address Prevalence and Treatment of Cardiovascular, Kidney and Metabolic Disease in Cancer Patients and Survivors
|
Opportunity Number
|
Funding Agency
AHA
|
Deadline
Jan 19 2026
|
|
Redefining Women's Health: From Heart to Head to Hormones
|
Opportunity Number
|
Funding Agency
AHA
|
Deadline
Jan 6 2026
|
|
Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
|
Opportunity Number
|
Funding Agency
NIH
|
Deadline
May 7 2026
PAR-25-254
|
|
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)
|
Opportunity Number
|
Funding Agency
NIH
|
Deadline
Feb 5 2026
PAR-25-337
|
|
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed)
|
Opportunity Number
|
Funding Agency
NIH
|
Deadline
Feb 16 2026
PAR-25-044
|
